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Summary 
 
Distal nephron acid secretion is mediated by highly specialized type A 
intercalated cells (A-ICs), which contain V-type ATPase-rich vesicles that fuse 
with apical plasma membrane upon demand. Intracellular bicarbonate 
generated by luminal H+ secretion is removed by the basolateral anion-
exchanger AE1. Chronically reduced renal acid excretion of distal renal 
tubular acidosis (dRTA) may lead to nephrocalcinosis and renal failure. A 
dominant-negative trafficking mechanism was proposed to explain AE1-
associated dominant dRTA based on unequivocal studies in MDCK 
monolayers. To test this hypothesis in vivo, we have generated a R607H 
knock-in mouse, which corresponds to the most common dominant dRTA 
mutation in human AE1, R589H. Heterozygous and homozygous R607H 
knock-in mice only displayed incomplete dRTA paralleled by the 
compensatory upregulation of the Na+/HCO3
- cotransporter NBCn1. Red 
blood cell Ae1-mediated anion-exchange activity and surface polypeptide 
expression were unchanged. Ae1 expression in A-ICs was greatly reduced, 
but basolateral targeting of the mutant protein was preserved. Unexpectedly, 
V-type ATPase expression was also reduced, and its plasma membrane 
targeting upon acid challenge compromised. Accumulation of p62- and 
Ubiquitin-positive material in A-ICs of knock-in mice suggested a defect in the 
degradative pathway, which may ultimately lead to loss of A-ICs. Type B 
intercalated cells were unaffected. We propose that reduced basolateral 
anion-exchange activity in A-ICs inhibits trafficking and regulation of V-type 
ATPase, compromising luminal H+ secretion and possibly also lysosomal 
acidification. 
(223 words) 
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Introduction 
 
The kidney plays a major role in acid-base homeostasis. Renal acidification 
defects do not necessarily result in overt systemic metabolic acidosis, but 
often lead to growth retardation, hypokalemia, osteomalacia, and 
hypercalciuria, with potential complications of nephrolithiasis or 
nephrocalcinosis 1. 
 
Net elimination of non-volatile acid is mediated by type A-intercalated cells (A-
ICs) in the connecting tubule (CNT) and collecting duct (CD). To achieve 
proton (H+) secretion, A-ICs express V-type ATPase at the apical cell pole 2. 
Protons are generated within these cells by hydration of CO2, which is a 
catalyzed by intracellular carbonic anhydrase type II (CAII). The resulting 
H2CO3 dissociates into H
+ and HCO3
-. While H+ is secreted apically via proton 
pumps, HCO3
- is extruded basolaterally by the chloride/bicarbonate 
exchanger AE1 (SLC4A1). This transport model is supported by hereditary 
defects, also known as distal renal tubular acidosis (dRTA), caused by 
mutations of proton pump subunits a4 or B1, of carbonic anhydrase CA II, or 
of anion-exchanger AE1, respectively 1 , 3. 
 
The SLC4A1 gene encodes two transcripts encoding erythroid variant eAE1 
and N-terminally truncated kidney variant kAE1. Global disruption of both 
variants in mice causes life-threatening hemolytic anemia and dRTA, whereas 
heterozygous knock-out mice are grossly normal 4, 5. In humans, AE1 
mutations can cause dRTA of either autosomal recessive or dominant type. 
Whereas most recessive forms of dRTA present early with nephrolithiasis, 
nephrocalcinosis and hemolytic anemia, dominant forms are usually 
diagnosed later in life and only rarely develop clinically apparent hemolytic 
anemia 6. The most common dominant variant, AE1 R589H, was shown to 
exhibit only mild reduction in anion-exchange activity 6. Retention of 
heterologous AE1 R589H in the endoplasmic reticulum of polarized MDCK 
cells, along with co-retention of co-expressed wild-type AE1, supported the 
hypothesis that dominant negative trafficking defects underlie autosomal 
dominant dRTA caused by heterozygous AE1 mutations 7.  
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To test this hypothesis in vivo, we generated mice expressing the variant 
R607H, corresponding to human variant R589H. Both heterozygous and 
homozygous knock-in mice exhibited incomplete dRTA, less severe in 
heterozygotes than in homozygotes. Targeting of Ae1 R607H to the 
basolateral plasma membrane of A-ICs was unexpectedly normal, as was 
transport activity in vivo. We further found that impaired targeting of the V-type 
ATPase and a decreased number of A-ICs underlie impaired acid secretion in 
both heterozygous and homozygous knock-in mice. 
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Results:  
 
Generation of Ae1 R607H knock-in mice  
We introduced the orthologous mouse Ae1 mutation R607H into murine 
embryonic stem (ES) cells by homologous recombination. The R607H 
mutation is located within transmembrane span 6 near its cytoplasmic end 8 
(Figure 1A,B). Homologous recombination was verified by Southern blot 
analysis exploiting the HindIII restriction site within intron 14 (Supplementary 
Figure 1A,B) and by sequence analysis (Figure 1C). Heterozygous and 
homozygous knock-in mice were viable and appeared grossly normal. 
Bodyweight did not differ between genotypes (Table 1). 
As observed in human dRTA patients heterozygous for AE1 R589H, R607H 
knock-in red blood cell counts and morphology were unaffected (Figure 1D 
and Table 1). Neither Masson-Goldner stain of kidney sections revealed gross 
structural abnormalities (Supplementary Figure 1C), nor Von Kossa stain 
revealed nephrocalcinosis or nephrolithiasis by age 3 months (Supplementary 
Figure 1D).  
 
Heterozygous and homozygous R607H knock-in mice display 
incomplete dRTA 
Although knock-in mice excreted urine that was more alkaline than that of 
their wild-type littermates, acid-base status and renal net acid excretion were 
comparable in all genotypes under baseline conditions (Table 1).  
As typical for renal acidosis plasma chloride levels were increased, while 
plasma [HCO3
-], pH and pCO2, which can change with respiration and are 
less robust, appeared unchanged. Interestingly, homozygous knock-in mice 
showed hypocalciuria, which is supported by the observation that increased 
urine pH may be associated with lower calcium excretion 9, although the 
mechanism remains unclear. 
We next challenged male Ae1+/R607H, Ae1R607H/R607H and wild-type littermates 
with 0.28 M NH4Cl in drinking water. All groups developed metabolic acidosis 
in response to NH4Cl administration, with decreased blood pH (Figure 1E) 
and plasma [HCO3
-] (Supplementary Figure 2A), associated with increased 
blood [Cl-] (Figure 1F).  
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During acid load, blood pCO2 was decreased independent of genotype, 
indicating respiratory adaptation (Supplementary Figure 2B). Urine pH 
decreased upon acute acid challenge. Only in wild-type mice blood pH (Figure 
1E) recovered to baseline and urine pH remained low during sustained acid 
loading (Figure 1G) due to increased net acid (Supplementary Figure 2C), 
NH4
+ (Figure 1H) and titratable acid excretion (Supplementary Figure 2D). 
Homozygous knock-in mice exhibited a more marked renal acidification defect 
and were completely unable to recover from the acid load, developing 
persistent post-treatment metabolic acidosis with reduced body weight 
secondary to reduced water and food intake (Supplementary Figure 2E-G).  
These data demonstrate incomplete dRTA in knock-in mice, a phenotype 
compatible with, but of lesser apparent severity than that of dRTA patients 
heterozygous for AE1 R589H 6. To exclude compensatory mechanisms in 
knock-in mice, we tested the expression of several acid/base transport 
proteins. We found no differences in NBC1 (Slc4a4), NHE3 (Slc9a3), AE2 
(Slc4a2) or H+/K+-ATPase subunit expression, but NBCn1 (Slc4a7), proposed 
to favor NH4
+ secretion in the collecting duct 10, was strongly upregulated 
(Figure 2A-C).  
 
The R607H/R589H kAE1 variant is correctly targeted to the basolateral 
plasma membrane of A-ICs. 
As in wild-type mice (Figure 3A,D), the kAe1 signal was clearly localized to 
the basolateral membrane in kidney sections of Ae1R607H/R607H mice (Figure 
3C,F and Supplementary Figure 3) indicating that normal targeting of the 
mutant polypeptide is preserved in both cortex and medulla. A typical 
basolateral signal was also obtained in Ae1+/R607H mice (Figure 3B,E and 
Supplementary Figure 3). The immunolabeling intensity, however, appeared 
less pronounced in Ae1+/R607H and Ae1R607H/R607H mice.  
Ultrastructural analysis of immunogold-labeled kAe1 further supports normal 
targeting of the R607H variant to the basolateral plasma membrane (Figure 
3G-I), but with lower labeling intensity than in WT mice. 
These unexpected localization prompted examination of human kAE1 R589H 
targeting in M-1 cells (Figure 3J,K and Supplementary Figure 3), derived from 
mouse cortical collecting duct, and in mIMCD-3 cells (Figure 3L,M and 
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Supplementary Figure 3), derived from mouse inner medullary collecting duct. 
In both cell models, targeting of kAE1 to the basolateral plasma membrane 
was unaffected by the mutation. 
These results, therefore, differ from those repeatedly observed in polarized 
MDCK cell monolayers, and thus argue against the prevailing concept that 
trafficking or targeting defects underlie human autosomal dominant dRTA 
caused by the AE1 R589H mutation. 
 
The R607H/R589H mutation does not impair Ae1-dependent chloride-
bicarbonate exchange activity in vitro and in vivo 
Cl-/HCO3
- exchange activity in IMCD-3 cells transfected with either wild-type 
kAE1, kAE1 R589H, or both was stimulated to similar extents upon 
extracellular Cl- removal (Figure 4A,B), suggesting that the R589H variant 
does not impair Cl-/HCO3
- exchange activity. Stopped-flow fluorimetry 
measurements (10) of Cl--dependent HCO3
- influx in resealed red blood cell 
ghosts similarly showed no difference in anion-exchange activity among 
genotypes (Figure 4C,D). Moreover, surface abundance of red cell eAe1 as 
assessed by FACS (Figure 4E,F) and total red cell eAe1 content 
(Supplementary Figure 4) in mutant mice were indistinguishable from 
corresponding values measured in wild-type red cells.  
  
kAe1 expression is reduced in the kidney of Ae1+/R607H and Ae1R607H/R607H 
mice 
Ae1 transcript abundance was reduced both in the cortex (Figure 5A) and in 
the medulla of Ae1+/R607H and Ae1R607H/R607H mice (Figure 5B), likely either 
reflecting decreased transcriptional efficiency, increased transcript 
degradation and/or decreased A-IC numbers.  
In accordance, kAe1 protein levels were strongly reduced in cortical and 
medullary lysates from both Ae1+/R607H and Ae1R607H/R607H mice (Figure 5C-D 
and Supplementary Figure 5). Ae1 immunostaining revealed not only 
decreased fluorescence intensity in individual cells, but also reduced numbers 
of kAe1-positive cells (Figure 5E). This decreased kAe1 immunoreactivity 
could reflect decreased protein stability of the R607H variant in intercalated 
cells. However, the ~24 h half-life of recombinant human kAE1 R589H-HA as 
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measured by pulse-chase experiments in both M1 cells (Figure 5F) and 
mIMCD-3 cells (Figure 5G) was indistinguishable from that of wild-type human 
kAE1-HA (See Supplementary Figure 6 for original immunoblots). These 
results resembled half-lives of the human wild-type and mutant proteins in 
HEK-293 cells 11 but differed greatly from the kAE1-R598H half-life of 1-2 
hours measured in polarized MDCK monolayers 7, 12. 
Although anion transport activities of mouse kAE1 R607H and human kAE1 
R589H are unchanged, the strongly decreased expression levels suggest that 
basolateral anion-exchange activity is severely compromised in renal A-ICs of 
Ae1+/R607H and Ae1R607H/R607H mice. 
 
Apical sorting of the proton pump is compromised in Ae1+/R607H and 
Ae1R607H/R607H mice 
Since intercalated cell kAE1 and V-type ATPase are functionally coupled, we 
assessed targeting of the V-type ATPase B1 subunit in mice at baseline 
(Supplementary Figure 7) and after acid challenge (Figure 6 and 
Supplementary Figure 8). After acid challenge the B1 subunit localized almost 
exclusively to the apical domain of A-ICs in WT mice (Figure 6A). However, in 
Ae1+/R607H (Figure 6B) and Ae1R607H/R607H (Figure 6C) mice this apical 
localization was severely compromised, suggesting altered proton pump 
targeting.  
Immunogold labeling of the A subunit of the V-type ATPase under baseline 
conditions confirmed decreased labeling of intracellular vesicles at the apical 
pole of A-ICs (Figure 6G-I). In contrast, V-ATPase labeling was preserved in 
B-ICs and overall Pendrin expression did not differ (Supplementary Figure 9). 
Total renal cortical B1 subunit abundance was decreased in acid-challenged 
mice as judged by cortical membrane fraction immunoblot (Figure 6J). 
  
The Ae1 R607H mutation causes a marked depletion of A-ICs, potentially 
caused by defective autophagy  
We co-stained kidney sections for Ae1, Pendrin, and the E-subunit of the V-
type ATPase in wild-type and mutant mice (Figure 7A and Supplementary 
Figure 10). Importantly, all Pendrin-negative cells that stained for the E-
subunit, i.e. A-ICs, also expressed Ae1. Conversely, Pendrin-positive cells B-
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ICs never co-stained with Ae1. In a separate experiment we also co-stained 
for Ae1, Pendrin, and Aquaporin 2 to identify principal cells (Figure 7B and 
Supplementary Figure 11). While the number of A-ICs was dramatically 
reduced in the cortex of both Ae1+/R607H and Ae1R607H/R607H mice, the number 
of B-ICs and principal cells remained unchanged. Therefore, the proportion of 
type A-to-B intercalated cells was significantly decreased (Figure 7C). This 
effect was even more pronounced after the acid challenge (Figure 7D).  
We also estimated the size of A-ICs by measuring the section area of 
individual A-ICs as described previously 13. A-ICs were larger in heterozygous 
and homozygous knock-in mice (Figure 7E). 
Ultrastructural analysis of A-ICs revealed that the typical intracellular vesicles 
observed in A-ICs of wild-type mice (Figure 8A,D,G) were depleted in 
Ae1+/R607H (Figure 8B,E,H) and Ae1R607H/R607H mice (Figure 8C,F,I). In contrast, 
the A-ICs of Ae1+/R607H and Ae1R607H/R607H mice contained numerous atypical 
lysosome-like vesicles reminiscent of autophagic structures (Figure 
8B,C,E,F,H,I) and multilamellar bodies (Figure 8I).  
In cortical (Figure 8J-L, Supplementary Figure 12) and medullary 
(Supplementary Figure 13) A-ICs in Ae1+/R607H and Ae1R607H/R607H mice co-
staining with p62, a receptor for intracellular toxic waste destined for 
autophagy 14, further supported the interpretation of autophagic vesicles. 
Importantly, these vesicular structures also partially co-localized with Ubiquitin 
(Figure 8M-O and Supplementary Figure 14), which marks proteins for 
degradation 15. 
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Discussion 
 
Mice genetically lacking Ae1 exhibited severe dRTA characterized by 
metabolic acidosis in nephrocalcinosis associated with hypercalciuria, 
hyperphosphaturia, and hypocitraturia, whereas heterozygous knock-out mice 
were unaffected 4. However, Ae1-deficient mice are also characterized by 
high peri- and postnatal lethality, most likely attributable to severe hemolytic 
anemia. The severe anemia and renal medullary hypoxia, accompanied by 
elevated levels of toxic free hemoglobin and pathological hemosiderosis all 
likely contribute to aggravation of the intrinsic defect in renal acid excretion. 
Indeed, sickle cell disease patients with hemolytic anemia and renal medullary 
ischemia often develop metabolic acidosis as part of sickle nephropathy 16.  
To study the role of Ae1 in the kidney independent of the red blood cell 
phenotype, we modeled the most common AE1 mutation found in dominant 
dRTA patients, AE1 R589H, in mice. Ae1R607H/+ mice were unable to 
maximally decrease urine pH or to increase urinary excretion of ammonium 
and titratable acid in response to acid as compared to wild-type. Homozygous 
knock-in mice were completely unable to recover from an acid load, 
developing a persistent metabolic acidosis following this challenge.  
The phenotype of R607H mice is mild compared to the usually complete 
dRTA observed in humans with the R589H mutation, although considerable 
variability of clinical presentation can be observed among affected individuals 
even within a family.  One possible explanation is diet, as the standard mouse 
chow provides a large net dietary alkali load 17, whereas the typical Western 
human diet constitutes a net acid load. Species-specific differences should 
also be considered, as these have been noted in other models, including the 
V-ATPase B1 subunit (Atp6v1b1) knock-out mouse generated in a mixed 
SVJ129/C57BL/6 background similar to that of our present study 18. Different 
to humans, mice may also have a compensatory upregulation of other 
transporters, since Ae1 disruption reduced Cl-/HCO3
- exchange in isolated 
outer medullary collecting duct by only 60 % 4. We here identified NBCn1 to 
be upregulated in heterozygous and even more so in homozygous knock-in 
mice. Since NBCn1 is a basolateral Na+/HCO3
- cotransporter of the medullary 
TAL, which was proposed to support NH4
+/NH3 excretion in chronic metabolic 
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acidosis 10, this upregulation may contribute to the mild phenotype of  
Ae1R607H/+ and  Ae1R607H/+ mice. 
 
While a dominant or co-dominant mis-targeting to the apical membrane was 
reported for a C-terminal truncation variant 19, 20, the kAE1 R589H variant 
exhibited a dominant negative intracellular retention phenotype in confluent 
polarized MDCK cells 7 as well as in nonpolarized HEK-293 cells 11. In stark 
contrast to results in MDCK cells basolateral Ae1 localization was preserved 
in heterozygous Ae1 R607H knock-in mice as judged by immunofluorescence 
and immunogold electron microscopy. Even in homozygous knock-in mice, 
mutant Ae1 localized at the basolateral membrane without accumulation in a 
cytoplasmic compartment, strongly suggesting normal targeting of the 
pathological R607H variant. Analysis in the cortical collecting duct cell line M1 
and in the medullary collecting duct cell line mIMCD-3 also revealed a 
predominant basolateral localization of the HA-tagged R589H variant.  
 
Previous studies reported that recombinant kAE1 R589H expressed in 
Xenopus oocytes showed a 20-50 % reduction in Cl−/Cl− and Cl−/HCO3
− 
exchange activity and did not display a dominant negative phenotype for 
anion transport when co-expressed with wild-type kAE1 6. Our stopped-flow 
fluorimetric measurements of Cl--dependent HCO3
- influx in resealed red cell 
ghosts revealed no genotype-dependent difference in transport activity. 
Transport activity was also unchanged in IMCD-3 cells transfected with the 
R589H variant.  
In remarkable contrast to the red blood cell, Ae1 expression in the kidney was 
strongly reduced. This observation is in line with a previous observation 
reporting strong reduction or absence of AE1 staining in renal cortex from a 
dRTA patient heterozygous for AE1 R589H 21. Thus basolateral bicarbonate 
efflux from renal A-ICs can be assumed to be reduced in correlation with the 
number of Ae1 alleles affected by the mutation.  
Acid secretion in Ae1+/R607H and Ae1R607H/R607H mice is further compromised by 
reduced plasma membrane abundance of V-type ATPase possibly reflecting a 
trafficking defect. This was particularly prominent in mice subjected to an acid 
challenge normally associated with massive translocation of the multimeric 
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pump from intracellular compartments to the apical plasma membrane of A-
ICs 2. Instead of the regular V-type ATPase positive vesicles we observed 
atypical vesicular structures, reminiscent of cell vacuolation in A-ICs of 
knockin mice, which can occur in response to different types of stress 22. 
Notably, the accumulation of intracellular p62- and Ubiquitin-positive 
structures in A-ICs of Ae1+/R607H and Ae1R607H/R607H mice suggests a defect in 
the degradative pathway and/or in autophagy 23, which may be related to 
defective lysosomal targeting of the V-type ATPase. Notably, impaired V-
ATPase activity due to inactivation of the renal (pro)renin receptor also 
resulted in multilamellar bodies and defects in autophagy 24. 
The mechanism by which kAe1 R607H severely perturbs V-type ATPase 
targeting in the absence of known physical association or subcellular 
colocalization remains unclear. Since impaired basolateral HCO3
- extrusion 
should alkalinize A-ICs, the pH dependence of microtubule assembly 25, actin 
polymerization/depolymerization 26-29, and other cytoskeletal dynamics may 
well contribute to the targeting defect. A similar mechanism has been 
proposed in a murine model of osteopetrosis for altered V-ATPase targeting in 
osteoclasts deficient in the basolateral anion-exchanger Ae2 30. In the kidney, 
microtubule disruption has dramatic effects on the polarized distribution of 
several important membrane proteins including the V-type-ATPase 31. 
 
Taken together, the data suggest that the R607H variant (and by extension, 
the R589H variant in humans) may disrupt the normal trafficking of V-type 
ATPase to the plasma membrane and lysosomes in A-ICs. The latter may 
explain accumulation of p62/Ubiquitin-positive structures, perhaps eventuating 
in the decreased total number of A-ICs, which perpetuates the acid secretion 
defect. These findings illustrate the considerable, context-dependent 
complexity of AE1-related kidney disease.  
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Concise methods 
 
All animal experiments were approved by the Thüringer Landesamt für 
Lebensmittelsicherheit und Verbraucherschutz (TLLV) in Germany. 
 
Generation of Ae1-R607H mice and metabolic parameters  
The generation of Ae1-R607H mice is described in the supplemental 
information. Urine was collected daily under mineral oil after adjustment to 
metabolic cages (Tecniplast, Buguggiate, Italy). Urine pH was measured with 
a microelectrode (InLab Micro pH, Mettler Toledo, Viroflay, France). Retro-
orbital blood was analyzed with the ABL 77 pH/blood-gas analyser 
(Radiometer, Copenhagen, Denmark).  
 
Immunohistochemistry and electron microscopy 
Kidneys were fixed by retrograde perfusion of the aorta with 4 % PFA in 
phosphate buffer and flash frozen in isopentane cooled with liquid nitrogen. 
The staining procedure and relevant antibodies are listed in the supplemental 
information. For electron microscopy tissues were further fixed in 2 % 
glutaraldehyde in 0.1 M sodium cacodylate pH 7.4 (Electron Microscopy 
Sciences, Hatfield, PA, USA) and subsequently treated with osmium tetroxide 
(Electron Microscopy Sciences). Ultrathin sections were stained with lead 
citrate and uranyl acetate and in a JEOL 1011 transmission electron 
microscope (TEM; JEOL, Peabody, MA, USA).  
 
Immunoblotting 
Kidneys were placed in ice-cold PBS, homogenized and membrane-enriched 
fractions were prepared by centrifugation. Proteins were separated by SDS-
PAGE and blotted onto a nitrocellulose membrane. Membranes were 
incubated with the respective antibodies for immunodetection with Pierce ECL 
Western Blotting Substrate (Thermo Scientific, Waltham, MA, USA), and 
analyzed by LAS 4000 ImageQuant (GE Healthcare, Little Chalfont, UK).  
 
Detailed methods are listed in the supplemental information. 
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Figure legends 
 
Figure 1. Ae1+/R607H and Ae1R607H/R607H knock-in mice show incomplete 
distal tubular acidosis. 
(A) Position of the human R589H mutation within the putative topology of AE1 
according to the model presented by 32. (B) Alignment of human AE1 R589 
with murine Ae1 R607. (C) Introduction of the modified codon verified by 
Sanger sequencing. (D) Red blood cells of heterozygous and homozygous 
knock-in mice displayed normal morphology. Scale bar: 10 µm. (E-H) After 3 
days under standard conditions to determine baseline values, Ae1+/+ (n=6; 
black diamond), Ae1+/R607H (n=10; blue square) and Ae1R607H/R607H (n=8; red 
triangle) mice were acid-challenged for 6 days with 0.28 M NH4Cl in drinking 
water. (E) Blood pH. (F) Blood [Cl-] in mM. (G) Urine pH. (H) Urinary NH4
+ 
excretion. Data are presented as mean ± SEM. **P<0.01, ***P<0.001, 
****P<0.0001 vs Ae1+/+ and #P<0.05, ##P<0.01 vs Ae1+/R607H (Two-way 
ANOVA). 
 
Figure 2. The bicarbonate transporter NBCn1 shows a compensatory 
increase in Ae1+/R607H and Ae1R607H/R607H mice. 
(A) Protein abundance of pH relevant transporters NBC, NHE3, NBCn1 and 
AE2 in protein lysates from whole kidney tissue under baseline conditions. 
Ae1+/+ (n=5), Ae1+/R607H (n=5), and Ae1R607H/R607H (n=4). (B) Quantification of 
NBC, NHE3, NBCn1, and AE2 protein abundance. The abundance of NBCn1 
is strongly increased in Ae1+/R607H and Ae1R607H/R607H mice. Data are 
presented as mean ± SEM. ***P<0.001, ****P<0.0001 vs Ae1+/+ (One-way 
ANOVA). (C) Fluorescence intensity for NBCn1 is increased in the TAL. Ae1 
(green), NBCn1 (red). Scale bar: 30 µm. 
 
Figure 3. The R607H/R589H variant is correctly targeted to the 
basolateral plasma membrane. 
(A-F) High magnification images of cortical collecting duct (A-C) and inner 
stripe of the outer medulla (D-F) in Ae1+/+, Ae1+/R607H and Ae1R607H/R607H 
showing that Ae1 R607H is localized to the basolateral pole of A-ICs. Scale 
bar: 10 µm. (G-I) The basolateral targeting of Ae1 R607H is evident from 
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immunogold labeling in cortical A-ICs. Scale bar: 250 nm. (J-M) M1 (J,K) or 
mIMCD-3 (L,M) cells expressing either human kAE1 WT-myc or R589H-HA 
were grown to confluency for 7 days on semi-permeable filters prior to 
fixation, permeabilization and detection of kAE1 with either mouse anti-myc or 
anti-HA antibody, followed by Cy3-coupled anti-Ig (red). Nuclei were stained 
with DAPI. Scale bar: 10 µm. 
 
Figure 4. The R607H/R589H mutation impairs AE1-dependent chloride 
bicarbonate exchange activity in vivo. 
(A) Representative (BCECF fluorescence ratio) intracellular pH traces from Cl-
/HCO3
- exchange experiments performed on mIMCD-3, mIMCD-3 kAE1 WT, 
mIMCD-3 kAE1 R589H or mIMCD-3 co-expressing kAE1 WT and R589H. 
The white and black rectangles above indicate incubations with NaCl and 
sodium gluconate containing solutions, respectively. (B) Transport rates of 
kAE1 WT, R589H or WT and R589H mutant are all similar in mIMCD-3 cells. 
(C) Anion-exchange traces of resealed red blood cell ghosts. (D) Anion-
exchange activity is identical in ghosts prepared from either Ae1+/+, Ae1+/R607H 
and Ae1R607H/R607H mice. (E) Fluorescence intensity of FACS-sorted red blood 
cells labelled with anti-Diego antibodies directed against different extracellular 
AE1 epitopes. (F) Quantitative comparison of AE1 surface expression in red 
blood cells from WT, Ae1+/R607H and Ae1R607H/R607H mice did not reveal 
differences among genotypes (n.s., one-way ANOVA and Tukey’s multiple 
comparisons test). Data are shown as mean ± SEM from a minimum of 3 
independent experiments (*P<0.05, **P<0.01 versus control, one-way 
ANOVA).  
 
Figure 5. AE1 expression is reduced in the kidney of Ae1+/R607H and 
Ae1R607H/R607H mice. 
(A,B) Quantitative RT-PCR shows that relative cortical Ae1 transcript 
abundance in Ae1+/R607H mice is only 40 % of wild-type levels and 15 % in 
Ae1R607H/R607 mice (A). Relative Ae1 medullary transcript abundance in 
Ae1+/R607H is 70 % of wild-type levels and 35 % in Ae1R607H/R607 (B). Data are 
presented as means ± SEM; n=3 each. (C-D) Ae1 protein abundance 
analyzed in protein lysates from cortex and medulla, is drastically reduced in 
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the cortex and only slightly less so in the medulla of Ae1+/R607H and 
Ae1R607H/R607 mice compared to wild-type. Data are presented as means ± 
SEM; n=5 per genotype. (E-F) Consistent with immunoblot results, Ae1 
immunoreactivity (red) in cortex (upper panels) and medulla (lower panels) is 
decreased in Ae1+/R607H and Ae1R607H/R607H mice relative to that in Ae1+/+ mice. 
Scale bar: 75 µm. (F,G) Quantification of time-dependent relative AE1 
abundance in M1 (F) and mIMCD3 (G) cells incubated with protein synthesis 
inhibitor, cycloheximide. Data are presented as means ± SEM; n=3 each. 
*P<0.05, **P<0.01, ***P<0.005, ****P<0.001 (One-way ANOVA and Tukey’s 
multiple comparison). 
 
Figure 6. Apical sorting of the proton pump is compromised in Ae1+/R607H 
and Ae1R607H/R607H mice 
(A-C) The B1 subunit of the V-ATPase of acid challenged WT mice almost 
exclusively localized to the apical domain of A-ICs in the cortex. In Ae1+/R607H 
and Ae1R607H/R607H mice, however, this shift to the apical domain did not occur, 
suggesting a secondary targeting defect of the proton pump in Ae1+/R607H and 
Ae1R607H/R607H mice. Scale bar: 10 µm. (D-I) Immunogold labeling of the A 
subunit of the V-type-ATPase. (D-F) Overview of A-ICs from WT, Ae1+/R607H 
and Ae1R607H/R607H mice. (G-I) Higher magnification view of the apical cell 
pole. Scale bar: 2 µm. (J-L) Higher magnification view of the basolateral cell 
pole. Scale bar: 1 µm. (J) Renal cortex immunoblot shows reduced B1 
subunit expression in both heterozygous and homozygous mice *P<0.05, 
****P<0.0001 compared to the WT (One-way ANOVA and Tukey’s multiple 
comparison). 
 
Figure 7. Cortical collecting ducts of Ae1+/R607H and Ae1R607H/R607H mice 
are depleted of A-ICs   
(A) Co-staining for Ae1 (red), Pendrin (blue), and the E-subunit (green) of the 
V-type ATPase. Pendrin-negative cells that stain for the E-subunit also label 
for Ae1 and thus represent A-ICs. Scale bar: 25 µm. (B) Co-staining for Ae1 
(red), Pendrin (blue), and Aquaporin 2 (green). Scale bar: 25 µm. (C,D) 
Quantification of A-ICs, B-ICs, and principal cells in the cortex at baseline (C) 
and after acid challenge (D). The number of cortical A-ICs is strongly reduced 
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in Ae1+/R607H and Ae1R607H/R607H mice. (E) Cross-sectional area of individual A-
ICs was increased in mutant compared to wild-type mice in the inner stripe of 
the outer medulla (ISOM). n=30 cells each. *P<0.05, **P<0.01, ***P<0.001 
(One-way ANOVA and Tukey’s multiple comparison). 
 
Figure 8. A-ICs accumulate p62+ structures in Ae1+/R607H and 
Ae1R607H/R607H mice 
(A-I) Compared to WT (A,D,G) the ultrastructural architecture of A-ICs of 
Ae1+/R607H (B,E,H) and Ae1R607H/R607H (C,F,I) mice is characterized by a 
depletion of the regular intracellular vesicles (arrow) and accumulation of 
lysosomal inclusions (arrowheads) and multilamellar bodies (asterisks). Scale 
bars: 2 µm (A-C) and 1 µm (D-F) and 500 nm (G-I). (J-L) Accumulation of 
p62+ deposits in Ae1-positive cells in the renal cortex of Ae1+/R607H and 
Ae1R607H/R607H mice but not in Ae1+/+ mice. Scale bar: 25 µm.  (M-O) p62 
positive structures in the renal cortex of Ae1+/R607H and Ae1R607H/R607H mice 
partially co-localize with Ubiquitin. Scale bar: 10 µm. 
 
Table 1. Baseline characterization of Ae1+/R607H and Ae1R607H/R607H mice 
In the basal state Ae1+/R607H and Ae1R607H/R607H mice have no detectable 
alterations in acid-base parameters revealing that, as in humans, R607H 
mutation causes incomplete dRTA with a higher urinary pH. The increase in 
blood chloride levels is consistent with the presence of a mild hyperchloremic 
metabolic acidosis. Values are means ± SEM, numbers of mice are indicated 
in brackets. *P<0.05, ****P<0.0001, vs Ae1+/+ (age 3-5 months, One-way 
ANOVA). 
 
 
 
TFFFAMMLRKFKNSSYF
TF   L  L    A  M          T      L  RKFKNS  T    YF
589
607
Human
Mouse
*
Ae1+/+ Ae1+/R607H Ae1R607H/R607H
A B
C D
FE
G H
HOOC
H2N
1      2      3     4     5             7      8      9      10     11          12       13    14*
6
Figure: 1
C T A A A
G
C A T
CGA ≈ R
CAT ≈ H
* L                         K
C T A A A GC G A
Ae1+/+ Ae1+/R607H
7.0
7.1
7.2
7.3
7.4
Day
*
***
NH4Cl 0.28M
B
lo
od
 p
H
0 3 6
100
110
120
130
140
Day
**
#
****
#
****
****
****
NH4Cl 0.28M
0 3 6
B
lo
od
 [C
l- ]
 m
M
-3 -2 -1
5.0
5.5
6.0
6.5
7.0
7.5
Day
****
****
#
#
U
rin
e 
pH
NH4Cl 0.28M
0 1 2 3 4 5 6
0
1.0
2.0
3.0
4.0
Day
****
****##
****
****
NH4Cl 0.28M
U
 N
H
4+
 m
m
ol
/d
ay
-2 0 3 6
▲  Ae1R607H/R607H■  Ae1+/R607H■  Ae1+/+
Ae1 NBCn1 Ae1 NBCn1 Ae1 NBCn1
A
D E
Figure: 2
B
C
R
el
at
iv
e 
pr
ot
ei
n 
ex
pr
es
si
on
A
e1
+/
+
A
e1
+/
R
60
7H
A
e1
R
60
7H
/R
60
7H
****
200
100
300
400
500
0
****
A
e1
+/
+
A
e1
+/
R
60
7H
A
e1
R
60
7H
/R
60
7H
A
e1
+/
+
A
e1
+/
R
60
7H
A
e1
R
60
7H
/R
60
7H
A
e1
+/
+
A
e1
+/
R
60
7H
A
e1
R
60
7H
/R
60
7H
***
NB
C1
NH
E3
NB
Cn
1
AE
2
NBC1 -
NHE3 -
NBCn1 -
AE2 -
Ae1+/+ Ae1+/R607H Ae1R607H/R607H
M
ed
ul
la
M1 AE1WT
IMCD-3 AE1WT IMCD-3 AE1R589H
M1 AE1R589H
Im
m
un
og
ol
d 
st
ai
ni
ng G H I
C
or
te
x
Figure: 3
J LK M
A B C
D E F
A B
0
1
2
3
4
5
6
7
Ae1+/+ Ae1+/R607H Ae1R607H/R607H
Fl
uo
re
sc
en
ce
C D
E
n.s
n.s
n.s
Figure: 4
0.5 sec
7.15
0 10 20 30 40 50 60
Time (sec)
pH
70 80 90 100
7.20
7.25
7.30
7.35
7.40
7.45
7.50
7.55
mIMCD kAE1 WT
mIMCD kAE1 R589H
mIMCD kAE1 WT + R589H
mIMCD
R
B
C
 c
ou
nt
Fluorescence intensity
F
Ae1+/+
Ae1+/R607H
Ae1R607H/R607H
0
50
100
150
Ae1+/+ Ae1+/R607H Ae1R607H/R607H
Su
rfa
ce
 e
xp
re
ss
io
n
(%
 o
f A
E1
+/
+ ) n.s
n.s
K
 (s
-1
)
0.00
0.05
0.10
0.15
0.20
0.25
mIMCDmIMCD kAE1
WT
mIMCD kAE1
R589H
mIMCD kAE1
WT + R589H 
*
**
n.s
n.s
pH
 v
ar
ia
tio
n 
(∆
pH
/m
in
)
**
*
050
100
150
Ae1+/+ Ae1+/R607H Ae1R607H/R607H
R
el
at
iv
e 
A
e1
 p
ro
te
in
 
ex
pr
es
si
on
0
50
100
150C
0.0
0.5
1.0
1.5
0.0
0.5
1.0
1.5
F G
A B
Ae1+/+ Ae1+/R607H Ae1R607H/R607H
**
**
n.s
*
n.s
n.s
Ae1+/+ Ae1+/R607H Ae1R607H/R607H Ae1+/+ Ae1+/R607H Ae1R607H/R607H
****
****
**
***
*
**
Ae1+/+ Ae1+/R607H Ae1R607H/R607H
C
or
te
x
M
ed
ul
la
Ae1
Ae1
E
R
el
at
iv
e 
A
e1
 m
R
N
A 
ex
pr
es
si
on
Figure: 5
D
C
or
te
x
C
or
te
x
M
ed
ul
la
M
ed
ul
la
R
el
at
iv
e 
A
e1
 m
R
N
A 
ex
pr
es
si
on
R
el
at
iv
e 
A
e1
 p
ro
te
in
 
ex
pr
es
si
on
0 10 20 30
0
50
100
150
Time (hours)
%
 o
f k
A
E1
 re
m
ai
ni
ng
AE1
R589H
0 10 20 30
0
50
100
150
Time (hours)
%
 o
f k
A
E1
 re
m
ai
ni
ng
AE1
R589H
Ae1+/+ Ae1+/R607H Ae1R607H/R607H
Ae1 B1A B C
****
****
Ae1+/+ Ae1+/R607H Ae1R607H/R607H
Ae1+/+ Ae1+/R607H Ae1R607H/R607H
D E F
G H I
J
Figure: 6
0
50
100
150
R
el
at
iv
e 
B
1 
su
bu
ni
t
 p
ro
te
in
 e
xp
re
ss
io
n
*
B1 -
Ae1+/+ Ae1+/R607H Ae1R607H/R607H
A
B
Ae1Pendrin E subunit
C D
Ae1Pendrin Aquaporin 2
Figure: 7
C
or
te
x
C
or
te
x
Basal conditions             Acid load
C
or
te
x
100
50
0
%
 o
f I
C
Ae
1+
/+
 Ae
1+
/R
60
7H
Ae
1R
60
7H
/R
60
7H
B-IC
A-IC
100
50
0
%
 o
f I
C
Ae
1+
/+
 Ae
1+
/R
60
7H
Ae
1R
60
7H
/R
60
7H
B-IC
A-IC
Ae
1+
/+
 Ae
1+
/R
60
7H
Ae
1R
60
7H
/R
60
7H
C
el
l s
iz
e 
(µ
m
  )2
250
200
150
100
50
0
***
***
n.s.E
IS
O
M
Ae1+/+ Ae1+/R607H Ae1R607H/R607H
J K L Ae1 p62
C
F
B
E
A
D
HG I
Ubiquitin p62 M N O
Figure: 8
*
**
	  	  	   	  	   Ae1+/+	   	  	   Ae1+/R607H	   	  	   Ae1R607H/R607H	   	  	  
G
en
er
al
	  
BW	   g	   24.45	   ±	   0.39	   (6)	   24.11	   ±	   0.31	   (10)	   23.76	   ±	   0.48	   (8)	  
Food	  Intake	   g/gBW/d	   0.17	   ±	   0.01	   (6)	   0.17	   ±	   0.01	   (10)	   0.17	   ±	   0.01	   (8)	  
Water	  Intake	  	   ml/gBW/d	   0.18	   ±	   0.02	   (6)	   0.18	   ±	   0.01	   (10)	   0.18	   ±	   0.01	   (8)	  
	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
Bl
oo
d	  
Hct	   %	   45	   ±	   0.65	   (13)	   45	   ±	   0.28	   (12)	   47	   ±	   0.80	   (9)	  
Hb	   g/dl	   15.1	   ±	   0.16	   (9)	   15.08	   ±	   0.16	   (13)	   15.3	   ±	   0.36	   (15)	  
Na+	   mM	   146	   ±	   0.36	   (13)	   147	   ±	   0.46	   (12)	   147	   ±	   0.47	   (9)	  
Cl-­‐	   mM	   111	   ±	   0.74	   (13)	   115	   ±	   0.77*	   (13)	   118	   ±	   1.44****	   (13)	  
K+	   mM	   4.56	   ±	   0.10	   (7)	   4.75	   ±	   0.07	   (7)	   4.45	   ±	   0.08	   (5)	  
Ca2+	   mM	   1.25	   ±	   0.01	   (13)	   1.26	   ±	   0.01	   (13)	   1.25	   ±	   0.01	   (12)	  
pH	  
	  
7.32	   ±	   0.02	   (13)	   7.32	   ±	   0.01	   (13)	   7.29	   ±	   0.02	   (12)	  
pCO2	   mmHg	   43	   ±	   1.19	   (12)	   46	   ±	   1.16	   (12)	   43	   ±	   0.92	   (11)	  
HCO3-­‐	   mM	   22	   ±	   0.55	   (13)	   22	   ±	   0.44	   (12)	   21	   ±	   0.70	   (12)	  
	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
U
rin
e	  
Urine	  Output	   ml/gBW/d	   0.075	   ±	   0.008	   (6)	   0.069	   ±	   0.005	   (10)	   0.065	   ±	   0.004	   (8)	  
Urine	  Osm	   mOsm/kgH2O	   3178	   ±	   383	   (6)	   2891	   ±	   246	   (10)	   2670	   ±	   108	   (8)	  
Urine	  pH	  
	  
6.45	   ±	   0.04	   (6)	   6.95	   ±	   0.05****	   (10)	   7.09	   ±	   0.05****	   (8)	  
Na+/Creat	   mmol/mmol	   17	   ±	   1.19	   (6)	   20	   ±	   0.68	   (10)	   21	   ±	   0.93	   (8)	  
K+/Creat	   mmol/mmol	   57	   ±	   11.69	   (6)	   63	   ±	   6.41	   (10)	   64	   ±	   5.99	   (8)	  
Ca2+/Creat	   mmol/mmol	   0.17	   ±	   0.02	   (6)	   0.15	   ±	   0.01	   (10)	   0.10	   ±	   0.01*	   (8)	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Supplementary Information 
 
 
 
Materials and Methods 
 
All animal experiments were approved by the Thüringer Landesamt für 
Lebensmittelsicherheit und Verbraucherschutz (TLLV) in Germany. 
 
Generation of Ae1R607H knock-in mice 
A clone isolated from a 129/SvJ mouse genomic  library (Stratagene, now Agilent, 
Santa Clara, CA, USA) was used to construct the targeting vector. A ~13.25 kb 
fragment including exons 2-18 of the Ae1 gene was cloned into the pKO-V901 
plasmid (Lexicon Genetics, The Woodlands, TX, USA) with a phosphoglycerate 
kinase (pgk) promoter-driven diphtheria toxin A cassette. A pgk promoter-driven 
neomycin resistance cassette flanked by loxP sites was inserted into the PciI site of 
intron 9. The R607H point mutation was introduced by site-directed mutagenesis into 
a subcloned BstZ17I-SpeI fragment (1541 bp) harboring exon 14. The construct was 
linearized with NotI and electroporated into R1 mouse embryonic stem (ES) cells. 
Neomycin-resistant clones were analyzed by Southern blot using HindIII and an 
external probe of 779 bp (Chromosome 11, 102350002-102350780) was amplified 
with primers "Ae1_SB1_for" (5'-GTC TAT ATG CAG GCC TTT GTC-3') and 
"Ae1_SB1_rev" (5'-CAT GAA AAG TGT CCT CCG T-3'). Two correctly targeted ES 
cell clones were injected into C57BL/6 blastocysts to generate chimeras. Chimeric 
mice were mated to a cre-Deleter mouse strain to remove the selection cassette (1). 
Studies were performed in a mixed 129Sv/C57BL/6 background in the F4 and F5 
generation. Genotypes were determined by PCR of tail biopsy DNA. For PCR 
genotyping, the forward primer F1 (5′-TAG CTC CTT CTA CCC CAC CCA-3′) and 
the reverse primer R1 (5′-CCA GAG GTA CAT GGT AAA ACA TTG TC-3′) were 
used in a single PCR mix allowing detection of the 189 bp wild-type allele and the 
320 bp knock-in (KI) allele. Detection of the introduced point mutation was performed 
by Sanger sequencing of the 498 bp PCR product amplified by forward primer F1 (5′- 
GCT CAA GTC AAG GCT TGG ATG G-3′) and reverse primer R1 (5′- CAA GGA 
TTC TGC TCA TCC GGA-3′).  
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NH4Cl loading 
We initially planned to study 8 mice of each genotype. However, as insufficient 
numbers of wild-type mice were available at the time metabolic cage experiments 
began, we increased the number of heterozygous mice. Thus, n=6 Slc4a1+/+; n=10 
Slc4a1R607H/+; n=8 Slc4a1R607H/R607H 3-month-old male littermates were housed in 
metabolic cages (Tecniplast, Buguggiate, Italy). Urine was collected daily under 
mineral oil. After adjustment to metabolic cages and recording of baseline 
parameters drinking water was supplemented with 0.28 M NH4Cl for 6 days.  
The pH of urine samples was measured with a pH microelectrode (InLab Micro pH, 
Mettler Toledo, Viroflay, France) and samples were immediately frozen before further 
analysis. Retro-orbital blood was collected at days 3 and 6 following acid loading and 
analyzed with the ABL 77 pH/blood-gas analyser (Radiometer, Copenhagen, 
Denmark). Urinary ammonium and titratable acid was measured by titration with a DL 
55 titrator (Mettler Toledo, Viroflay, France). Urine osmolalities were determined by 
freezing point osmometer (Roebling, Berlin, Germany). Urine creatinine was 
measured by Jaffé colorimetric method. Urinary Na+ and K+ were measured by flame 
photometry (IL 943; Global Medical Instrumentation, Ramsey, MN, USA). Urine 
aldosterone was measured via RIA (DPC Dade Behring, now Siemens Healthcare, 
Erlangen, Germany). 
 
Histology and immunohistochemistry 
Kidneys were fixed by retrograde perfusion of the aorta with 4 % PFA in phosphate 
buffer. Dissected kidneys were washed in ice-cold PBS for 30 minutes and flash 
frozen in isopentane cooled with liquid nitrogen. 6 µm thick cryosections were 
subjected to Masson-Goldner stain or von Kossa stain. Kidney sections from a4 
knockout mice served as a positive control (2). For immunohistochemistry, 
cryosections were blocked with goat or donkey serum (3). Sections were incubated 
overnight at 4°C with primary antibody, washed with PBS, incubated with 
fluorophore-conjugated secondary antibody, washed with PBS and then mounted 
with Glycergel mounting medium (DAKO/Agilent, Santa Clara, CA, USA). Each 
experiment included three mice per group. Representative images were acquired 
with a Confocal SP8 workstation (Leica, Wetzlar, Germany). 
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Cell culture 
M1 (cortical collecting duct cells, ATCC CRL-2038) and mIMCD-3 cells (ATCC CRL-
2123) underwent infection with mouse moloney leukemia virus to induce quasi-stable 
expression of human kidney anion exchanger 1 (kAE1) WT-myc, of R589H-HA (the 
human equivalent of R607H), or of both kAE1 WT-myc and kAE1 R589H-HA, as 
previously described (4). However, despite continued G418 exposure of cell cultures 
(1 mg/ml for M1 cells; 2 mg/ml for mIMCD-3 cells), kAE1 protein expression declined 
over a two-to-three week period. For immunostaining, cells were grown for 7 days on 
semi-permeable filter supports, fixed with 4 % paraformaldehyde, quenched, rinsed, 
and blocked with 0.1 % Triton X-100, followed by 1 % bovine serum albumin in PBS. 
Epitope-tagged kAE1 proteins were detected either with mouse anti-myc (Cell 
Signalling, Danvers, MA, USA) or mouse anti-HA antibodies (Covance, Princeton, 
NJ, USA), each followed by Cy3-coupled anti-mouse Ig (Jackson ImmunoResearch 
laboratories, West Grove, PA, USA). Samples were examined with an IX81 
microscope (Olympus, Tokyo, Japan) equipped with a Nipkow spinning-disk (Quorum 
Technologies, Guelph, Canada).   
 
Counting of intercalated and principal cells 
Kidney sections were co-stained either for AE1, pendrin, and V-type ATPase E 
subunit (Atp6v1e1) or for AE1, pendrin, and AQP2. Ten random fields from cortex 
and inner stripe of the outer medulla (ISOM) were acquired at 20X magnification. 
Numbers of principal cells (defined by apical expression of AQP2), type A 
intercalated cells (basolateral AE1 expression), and type B intercalated cells (apical 
pendrin expression) were counted (n=3 mice per genotype).  
 
Electron microscopy 
After perfusion in situ with 4 % PFA as above, tissues were shipped in fixative to 
Boston, where they were further fixed in 2 % glutaraldehyde in 0.1 M sodium 
cacodylate pH 7.4 (Electron Microscopy Sciences, Hatfield, PA, USA). Tissues were 
then rinsed in cacodylate buffer and post-fixed in 1 % osmium tetroxide (Electron 
Microscopy Sciences) in 0.1 M cacodylate buffer for 1 h at room temperature, and 
then rinsed as above. After washing in double distilled water, the samples were 
stained, en bloc, in an aqueous solution of 2 % uranyl acetate for 1 h at room 
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temperature. The samples were rinsed in water and dehydrated through a graded 
ethanol series to 100 % ethanol, then infiltrated with EPON (Ted Pella Inc., Redding, 
CA USA) in a solution of 1:1, EPON: 100 % ethanol overnight. They were then 
placed in fresh EPON for several hours and subsequently embedded in EPON 
overnight in a 60°C oven. Ultrathin sections were cut on a Leica EMUC7 
ultramicrotome (Leica), collected on formvar-coated grids, stained with lead citrate 
and uranyl acetate, and examined at 80 kV in a JEOL 1011 transmission electron 
microscope (TEM; JEOL, Peabody, MA, USA). Images were acquired using an AMT 
digital imaging system (Advanced Microscopy Techniques, Danvers, MA, USA). 
For immunogold staining, samples fixed in 4 % paraformaldehyde alone were 
embedded in LRWhite resin as previously described (5). Ultrathin sections were 
incubated 2 h with anti-AE1 or V-type ATPase antibodies (6), rinsed, and incubated 
45 min with gold-labeled goat anti-guinea-pig Ig (Ted Pella). Sections were rinsed 
again in PBS and counterstained with lead citrate and uranyl acetate before imaging 
as above in the JEOL 1001 TEM. 
 
Immunoblotting 
Mice were perfused transcardially with PBS at RT. Perfused kidneys were placed in 
ice-cold PBS and homogenized in ice-cold isolation buffer (250 mM sucrose, 20 mM 
Tris-Hepes, pH 7.4) supplemented with protease inhibitor cocktail (Complete; Roche 
Diagnostics, Risch-Rotkreuz, Switzerland) and phosphatase inhibitor cocktail 
(PhosSTOP; Roche Diagnostics). Cellular debris was removed by centrifugation at 
4,000 g for 15 min at 4°C. Membrane-enriched fractions were prepared by 
centrifugation at 17,000 g for 30 min at 4°C. Protein concentration was determined 
using the Bradford protein assay (microBradford, BioRad, Hercules, CA, USA). Total 
homogenates and membrane-enriched fractions were prepared with 6x SDS-loading 
buffer (0.375 mM Tris-HCl pH 6.8, 12 % SDS, 0.6 M dithiothreitol, 60 % glycerol and 
bromophenol blue) and incubated 30 min at room temperature. 15-30 µg of protein 
were loaded on 10 % polyacrylamide gels (XCell SureLock Mini-cell; Invitrogen Life 
Technologies, Carlsbad, CA, USA) separated and blotted onto a nitrocellulose 
membrane. Membranes were blocked with 5 % milk in TBS and incubated overnight 
at 4°C with the primary antibody. The secondary horseradish-conjugated anti-Ig 
antibody was incubated on membranes for 2 hrs at RT, detected with Pierce ECL 
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Western Blotting Substrate (Thermo Scientific, Waltham, MA, USA), and analyzed by 
LAS 4000 ImageQuant (GE Healthcare, Little Chalfont, UK).  
 
Half-life measurement 
M1 or mIMCD-3 cells expressing kAE1 WT-myc or kAE1 R589H-HA were plated to 
sub-confluency on 6-well plates, then incubated 0, 4, 8, 16 or 24h with 10 µg/ml 
cycloheximide in DMEM:F12 culture medium supplemented with 10 % fetal bovine 
serum and 1 mg/ml penicillin/streptomycin. Cells were lysed in PBS containing 1 % 
Triton X-100, 1 μg/ml aprotinin, 2 μg/ml leupeptin, 1 μg/ml pepstatin A, and 100 μg/ml 
PMSF. kAE1 polypeptides were subjected to immunoblot analysis using mouse anti-
HA or anti-myc antibody, followed by horseradish peroxidase-coupled anti-mouse Ig 
(Cell Signaling). Bound peroxidase was detected by enhanced chemiluminescence 
(ECL Prime; GE Healthcare) and relative band intensities were analyzed with 
ImageJ. 
 
AE1-mediated transport activity in red blood cells by stopped-flow analysis 
200 µl mouse blood was washed three times in PBS. Washed red blood cells were 
resuspended in 32 ml hypotonic lysis buffer (7 mM KCl, 10 mM Hepes/KOH, pH 7.2) 
for 40 min on ice, followed by resealing for 1h at 37°C in resealing buffer (100 mM 
KCl, 10 mM Hepes/KOH, pH 7.2, 1 mM MgCl2 and 2 mg/ml bovine carbonic 
anhydrase) containing 0.15 mM of the fluorescent pH sensitive dye pyranine (1-
hydroxypyrene-3,6,8-trisulfonic acid, Sigma-Aldrich, St. Louis, MO, USA). After three 
washes in ice-cold incubation buffer (100 mM KCl, 10 mM Hepes/KOH, pH 7.2), 
resealed ghosts were kept on ice until stopped-flow experiments were performed (7) 
at 30°C (SFM400; Bio-logic, Grenoble, France). Excitation was at 465 nm and 
emitted light was filtered with a 520 nm cut-off filter. For measurement of HCO3
-/Cl- 
exchange activity, dye-loaded ghosts resuspended in 3 ml “chloride buffer” (100 mM 
KCl and 10 mM HEPES/KOH pH 7.2) were rapidly mixed with an equal volume of 
bicarbonate buffer (100 mM KHCO3 and 10 mM HEPES/HCl pH 7.2), generating an 
inwardly directed HCO3
-/CO2 gradient of 50 mEq/L and an outwardly directed Cl
- 
gradient of equal magnitude. Data from six-to-eight time courses were averaged and 
fit to a mono-exponential function using the simplex procedure of Biokine software 
(Bio-logic).  
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Surface AE1 expression on erythrocytes was determined by immunostaining with an 
anti-Diego b (Dib) antibody followed by flow cytometric analysis on a FACSCanto II 
flow cytometer (Becton-Dickinson, Franklin Lakes, NJ, USA). Secondary antibodies 
were goat anti-human PE-conjugated F(ab’)2 fragments (Beckman Coulter, Brea, 
CA, USA). Results were analysed using FlowJo software (FlowJo, Ashland, OR, 
USA). 
 
AE1 transport in mIMCD-3 cells  
mIMCD-3 cells expressing either kAE1 WT, R589H, or WT and R589H mutant were 
grown on glass coverslips to 70 % confluence. AE1 transport activity was measured 
using BCECF-AM (Sigma-Aldrich) as described previously (8). After washing with 
serum-free OptiMEM medium (Gibco/ Thermo Fisher), coverslips were incubated 
with 10 µM BCECF-AM (Sigma-Aldrich) for 10min at 37°C. Coverslips were then 
placed in fluorescence cuvettes and the cells were perfused at room temperature 
with: 5 mM glucose, 5 mM K+ gluconate, 1 mM Ca2+ gluconate, 1 mM MgSO4, 10 mM 
Hepes, 2.5 mM NaH2PO4, 25 mM NaHCO3, 140 mM chloride, followed by a chloride-
free medium containing 140 mM gluconate to induce intracellular alkalization. 
Solutions were continuously bubbled with 5 % CO2. Using a PTI fluorimeter (Photon 
Technologies International (PTI), Edison, NJ, USA), fluorescence was excited at 440 
and 490 nm, and fluorescence emission was recorded at 510 nm. Intracellular 
BCECF fluorescence was calibrated with buffers at pH values of 6.5, 7.0, or 7.5, 
each containing 100 μM nigericin sodium salt. Cellular anion exchange rates were 
determined by linear regression of the initial 60 s of fluorescence perturbation, and 
normalized to pH calibration measurements, using FelixGX 4.1.0 software (PTI). 
Results represent > 3 independent experiments.  
 
Reverse transcription and quantitative PCR 
Total RNA (2 µg from renal cortex or medulla; 5 µg from liver) was reverse- 
transcribed with SuperScript III Reverse Transcriptase (Invitrogen Life Technologies, 
Carlsbad, CA, USA) as described previously (9). Duplicate qPCR reactions were 
perfomed with SsoFast EvaGreen Supermix (BioRad, Hercules, CA, USA) using a 
CFX96 Touch Real-Time PCR Cycler (BioRad). Primer sequences were "flAe1_for" 
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(5'-CCCCATACACCATCCTCTC-3', "flAe1_rev" (5'-CGGTTATGCGCCATGGA-3'), 
and the ActB Quantitect Primer Assay QT01136772 (Qiagen, Hilden, Germany). 
 
Antibodies 
Primary antibodies use in this study: rabbit anti-NBCn1 (Kwon et al. AJP 282: F341-
F351, 2002; PMID 11788449) (Western Blot 1:5000; Immunofluorescence 1:2500); 
rabbit anti-rkNBC1 (not clear) (WB 1:5000); rabbit anti-NHE3 (Catalog number SPC-
400, StressMarq Biosciences, Victoria, BC, Canada); rabbit anti-AE2 (Frische AJP 
renal 2004 PMID 14749257) (WB 1:3000); rabbit anti-pendrin (10) (WB 1:10000); 
rabbit anti-Atp6v1b1 subunit (11) (WB 1:30,000); chicken anti-Atp6v1e1 subunit (12) 
(IF 1:500); rabbit anti-Atp6v0a4 subunit (6) (1:500); guinea pig anti-AE1 (6) (IF 
1:5000); guinea pig anti-pendrin (6) (IF 1:1000); goat anti-AQP2 (C-17; Santa Cruz, 
Dallas, TX, USA) (IF 1:1000); sheep anti-CA2 (AHP206; Serotec, Kidlington, UK) (IF 
1:500); anti-Diego b (1:4) human monoclonal antibodies were kindly donated by Dr. 
M. Uchikawa, Japanese Red Cross Central Blood Center, Tokyo; mouse anti-HA 
(Covance, Princeton, NJ, USA) (IF 1:500 and WB 1:1500); mouse anti-myc (Cell 
Signalling, Danvers, MA, USA) (IF 1:500 and WB 1:1500). 
Secondary antibodies used in this study: goat anti-rabbit Alexa 555 (Invitrogen, 
Carlsbad, CA, USA) (1:2000); goat anti-rabbit Alexa 488 (Invitrogen) (1:2000); goat 
anti guinea pig Alexa 555 (Invitrogen) (1:2000); goat anti guinea pig Alexa 488 
(Invitrogen) (1:2000), anti-mouse coupled to HRP (Cell signalling, Danvers, MA, 
USA) (WB 1:10000), anti-rabbit coupled to HRP (Cell signalling, Danvers, MA, USA) 
(WB 1:10000). 
   
Cell surface measurements  
The cell surface of type A intercalated cells (basolateral AE1 and apical B1 subunit 
localization) was determined in the inner stripe of the outer medulla with ImageJ. 
Briefly, a grid of arbitrary size was placed on immunohistochemistry pictures and the 
stained cell area within each grid was calculated as a ratio of unit grid. To avoid 
biased measurements of type A intercalated cells 5 different randomly selected grid 
sizes were applied and the mean calculated (13). In total, type A intercalated cells of 
2 different mice per genotype were measured. Cortical type A intercalated cells were 
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not measured due to weak staining in heterozygous and homozygous Ae1-R607H 
knock-in mice. 
 
Statistics 
The three genotype groups were compared by one-way ANOVA followed by Tukey’s 
multiple comparisons test. P-value < 0.05 was considered significant. 
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Supplementary Figures 
 
 
Supplementary Figure 1. (A) Targeting and screening strategy. Top: murine Ae1 
locus; middle: targeted locus; lower: locus after Cre-mediated removal of the 
selection cassette. (B) Clones were screened by Southern blot using HindIII and an 
external probe as indicated. The probe detected a 20 kb WT fragment and a 4.8 kb 
targeted fragment. (C) Histological analysis of mouse kidney sections at 3 months of 
age revealed no abnormalities (Masson Goldner, scale bar 50 µm). (D) Von Kossa 
stain revealed no detectable nephrocalcinosis (scale bar 50 µm). 
 
Supplementary Figure 2. (A-G) After 3 days under standard conditions to determine 
baseline values, Ae1+/+ (n=6; diamond), Ae1+/R607H (n=10; square) and Ae1R607H/R607H 
(n=8; triangle) mice were acid-challenged for 6 days with 0.28 M NH4Cl in drinking 
water. (A) Blood [HCO3
-]. (B) Blood pCO2. (C) Urinary net acid excretion (NAE). (D) 
Urinary titrable acid (TA). (E) Body weight. (F) Water intake. (G) Food intake. Data 
are presented as mean ± SEM. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 indicated 
for Ae1+/R607H or Ae1R607H/R607H vs. Ae1+/+, other data points not significant, Ae1+/R607H 
vs. Ae1R607H/R607H no significant difference at any time point (Two-way ANOVA). 
 
Supplementary Figure 3. Grey scaled images of the immunofluorescence stainings 
displayed in Figure 3. Scale bars: 10 µm. 
 
Supplementary Figure 4. (A) Coomassie blue stained gel of RBC lysates from WT 
(n=4), Ae1+/R607H (n=5), and Ae1R607H/R607H (n=5) mice (B) Quantification of Ae1 
protein expression normalized to actin. No significant differences between 
genotypes. 
 
Supplementary Figure 5. Representative western blots for Ae1 protein abundance 
in protein lysates from cortex (A) and medulla (B) of WT, Ae1+/R607H and Ae1R607H/R607 
mice.  
 
Supplementary Figure 6. Representative western blot for pulse-chase experiments. 
(A) M1 cells transfected with human kAE1-WT. (B) M1 cells transfected with human 
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kAE1-R589H. (C) mIMCD-3 cells transfected with human kAE1-WT. (D) mIMCD-3 
cells transfected with human kAE1-R589H. Unfilled circles indicate non-glycosylated 
protein; filled circles indicate glycosylated protein. 
 
Supplementary Figure 7. Merged channels (A-C) for co-immunostainings for the 
Ae1 (D-F) and the B1 subunit of the V-type ATPase (G-I) in inner stripe of outer 
medulla under baseline conditions. Single channels for Ae1. (G-I) Single channel for 
B1. Scale bars: 10 µm. 
 
Supplementary Figure 8. Merged channels (A-C) for co-immunostainings for the 
Ae1 (D-F) and the B1 subunit of the V-type ATPase (G-I) in inner stripe of outer 
medulla under acid challenge. Single channels for Ae1. (G-I) Single channel for B1. 
Scale bars: 10 µm. 
 
Supplementary Figure 9. Immunogold labelling of the A subunit of the V-type 
ATPase in type B intercalated cells in the cortex. (A-C) Overview from WT, Ae1+/R607H 
and Ae1R607H/R607H mice. Scale bar: 2 µm. (D-F) Magnification of the basolateral cell 
pole. Scale bar: 1 µm (G-I) Magnification of the apical cell pole. Scale bar: 1 µm. (J) 
Pendrin protein abundance analyzed in whole kidney protein lysates is unchanged in 
Ae1+/R607H and Ae1R607H/R607 mice compared to wild-type mice. Data are presented as 
means ± SEM; n=5 for wild-type and Ae1+/R607H, n=4 Ae1R607H/R607H mice. 
 
Supplementary Figure 10. (A-C) Renal cortex showing merged channels of the co-
staining for Ae1 (red), Pendrin (blue), and the E-subunit (green) of the V-type 
ATPase. (D-F) Single channels for Ae1. (G-I) Single channels for the E subunit. (J-L) 
Single channels for Pendrin. Scale bars: 25 µm.  
 
Supplementary Figure 11. (A-C) Renal cortex showing merged channels of the co-
staining for Ae1 (red), Pendrin (blue), and Aquaporin 2 (green). (D-F) Single 
channels for Ae1. (G-I) Single channels for Aquaporin 2. (J-L) Single channels for 
Pendrin. Scale bars: 25 µm.  
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Supplementary Figure 12. (A-C) Renal cortex showing merged channels of the co-
staining for Ae1 (red), p62 (green), and DAPI (blue). (D-F) Single channels for Ae1. 
(G-I) Single channels for p62. (J-L) Single channels for DAPI. Scale bars: 25 µm. 
 
Supplementary Figure 13. (A-C) Renal medulla showing merged channels of the 
co-staining for Ae1 (red), p62 (green), and DAPI (blue). (D-F) Single channels for 
Ae1. (G-I) Single channels for p62. (J-L) Single channels for DAPI. Scale bars: 25 
µm. 
 
Supplementary Figure 14. (A-C) Renal cortex showing merged channels of the co-
staining for Ubiquitin (red), p62 (green), and DAPI (blue). (D-F) Single channels for 
Ubiquitin. (G-I) Single channels for p62. (J-L) Single channels for DAPI. Scale bars: 
10 µm. 
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